Date: 4.12.2013
Technology request: A novel immunomodulatory peptide that can be used for treatment of infectious diseases, Cardiovascular Ischemia/Reperfusion injury, Acute Kidney Injury and Multiple Myeloma
Reference: 12 IL 80EP 3O1C
Summary: An Israeli clinical stage biotechnology company is looking for a partner to collaborate on developing its lead compound, a short peptide antagonist of CD28, for treatment of immune related diseases. The company is seeking to collaborate with service providers, academic researchers and clinical investigators in the fields of drug development (preclinical and clinical) in the area of Cardiovascular Ischemia reperfusion injury and multiple myeloma.
For more information click here.
Technologické nabídky a poptávky zpracovává BIC Plzeň, partner sítě Enterprise Europe Network.
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2024 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
Biotech - International biotech science
Biotechnology projecst no.10 - 10th page of our biotechnology projects database
Biocompatible nanoparticles modified with ATP can enhance systemic delivery of cancer immunotherapy
New possibilities for the medical use of botulinun toxin A1